Should a male patient be prescribed both tadalafil and sildenafil simultaneously?

No, a male patient should not be on both tadalafil and sildenafil simultaneously for erectile dysfunction

Standard clinical practice dictates using only one PDE5 inhibitor at a time, not combining multiple agents from the same drug class. Both tadalafil and sildenafil are phosphodiesterase type 5 inhibitors (PDE5Is) that work through the same mechanism of action, and combining them offers no established benefit while potentially increasing adverse events 1.

Why Not Both?

Same Mechanism, Redundant Action

• Both drugs inhibit the same enzyme (PDE5) through identical pathways
• The 2025 European Association of Urology guidelines and 2018 AUA guidelines discuss sildenafil, tadalafil, vardenafil, and avanafil as alternative options to choose from—not to combine 2, 1
• Guidelines emphasize selecting one PDE5i based on patient preference and intercourse frequency, then titrating that single agent to optimal efficacy 1

Increased Risk Without Benefit

• Combining PDE5Is would amplify adverse events including:
  • Headache, flushing, dyspepsia
  • Hypotension (both act as vasodilators)
  • Visual disturbances
  • Priapism risk 3
• No guideline recommends concurrent use of multiple PDE5Is 2, 1

The Correct Approach

Choose One Agent and Optimize

1. Select a single PDE5i based on:

   • Tadalafil: Longer duration (up to 36 hours), preferred for frequent intercourse or daily dosing 2
   • Sildenafil: Shorter acting (4-6 hours), preferred for on-demand use 1

2. Titrate the dose of your chosen agent to find optimal efficacy while minimizing adverse events 1

3. If inadequate response to one PDE5i:

   • Verify correct usage (sexual stimulation required, timing, avoid large meals) 1
   • Consider switching to a different PDE5i (limited evidence but reasonable) 2
   • Add testosterone therapy if hypogonadal 1
   • Consider combination with other modalities (vacuum devices, intracavernosal injections) 2, 1

Important Caveat: One Research Exception

One 2015 study 4 examined combining daily tadalafil 5 mg with sildenafil 50 mg as needed in severe ED patients, showing some benefit. However, this single study does not override established guidelines, and this approach remains experimental and not standard practice. The study design (combining daily low-dose tadalafil with as-needed sildenafil) differs from simply prescribing both drugs simultaneously.

Clinical Bottom Line

Prescribe one PDE5i, optimize its dose, ensure proper usage, and only consider alternative strategies if monotherapy fails after appropriate titration. Combining tadalafil and sildenafil simultaneously is not supported by guidelines, increases adverse event risk, and should not be done in routine clinical practice 2, 1.